Carrie leads Mirvie’s efforts to develop the proprietary Mirvie RNA platform. The platform is first to predict unexpected complications months before symptoms occur by revealing the underlying biology of each pregnancy. It opens a new window into pregnancy health for women to act and their doctors to intervene before unexpected complications become a crisis. Mirvie is shaping the future of pregnancy health by enabling proactive, preventive, and personalized pregnancy care for the well-being of moms and babies. As a board-certified genetic counselor, Carrie’s direct patient care focused on high-risk prenatal care and providing broad access to new diagnostic technologies. She led clinical teams at Massachusetts General Hospital and Sutter Health. Her direct-clinical experience served as the foundation for leading-edge product development at Counsyl, Myriad, and Miroculus.
Shaping The Future of Pregnancy Health with RNA
1 in 5 pregnancies experience unexpected complications, yet there is no reliable way to detect them. The Mirve RNA platform reveals a fundamental understanding of the underlying biology of each pregnancy, including predicting pregnancy complications months before symptoms occur – a breakthrough enabling earlier and more effective interventions for millions of pregnancies.
Aleksandar Rajkovic, UCSF
Researchers have long been recognizing the uniqueness of women’s health and its substantial effect on clinical practice, acknowledging the increasing appreciation of the importance of multidisciplinary approaches to health and disease. In every organ system, there are diseases that are unique to women, more common in women than in men, or characterized by differences in disease course in women compared to men. This Track will focus on the following topics related to Women’s Health: